Anicom Holdings (8715) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
13 Jul, 2026Executive summary
Recurring revenue rose 9.1% year-over-year to JPY 73,846 million, driven by strong new policy acquisition, robust pet insurance demand, and policy transfers from other insurers.
Recurring profit declined 28.3% year-over-year to JPY 3,543 million, mainly due to policy transfer costs and investments in new business initiatives, but exceeded internal plan by 7.4%.
Net profit attributable to owners of parent decreased 32.1% year-over-year to JPY 2,204 million, primarily due to higher underwriting and administrative expenses.
Number of policies in force increased by 8.1% to 1,392,772, reflecting strong sales and marketing efforts.
Combined ratio rose to 95.0% (up 2.1 points), reflecting higher medical expenses and policy transfer costs.
Financial highlights
Underwriting revenue increased 8.9% year-over-year to JPY 64,103 million; investment revenue grew 3.4% to JPY 1,640 million, exceeding plan.
Other recurring revenue rose 12.0% to JPY 8,103 million.
Recurring expenses increased 12.1% to JPY 70,303 million, with underwriting expenses up 11.2%.
Operating and general administrative expenses rose 16.0% to JPY 20,706 million.
Basic earnings per share was 29.77 yen (down from 41.98 yen); equity ratio was 37.9%.
Outlook and guidance
FY03/27 recurring revenue is forecast at JPY 81,000 million, up 9.7% year-over-year; recurring profit is projected to rise 41.1% to JPY 5,000 million; net profit forecast at JPY 3,250 million (+47.4%).
Mid-term plan targets recurring revenue of JPY 80-85 billion and recurring profit of JPY 6.8-7.3 billion by FY03/28.
Dividend per share forecast for next year is 13.50 yen, targeting a 30% payout ratio, with continuous dividend increases and flexible share buybacks.
Focus on diversifying sales channels, reducing policy acquisition costs, and expanding non-insurance businesses.
Latest events from Anicom Holdings
- Double-digit profit and revenue growth driven by new policies and strong pet insurance demand.8715
Q3 202513 Jul 2026 - Record-high revenue and profit driven by pet insurance growth and investment gains, with lower profit forecasted.8715
Q4 202513 Jul 2026 - Revenue up 10.4% YoY, but profit down over 40% amid higher expenses and policy transfer costs.8715
Q1 202613 Jul 2026 - Recurring revenue and profit surged on strong pet insurance demand and operational efficiency.8715
Q1 202513 Jul 2026 - Double-digit recurring revenue and profit growth driven by robust pet insurance demand.8715
Q2 202513 Jul 2026 - Recurring revenue up 10.6% YoY, but profit fell on higher expenses and one-time costs.8715
Q3 202613 Jul 2026 - Recurring revenue up 10.6% YoY, but profit down 34.4% amid higher expenses and loss ratios.8715
Q2 202613 Jul 2026